Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010–2013 French Health Insurance data - Scailteux, L-M; Vincendeau, S; Balusson, F (European Journal of Cancer, 2017)
et al.